BNP Paribas Financial Markets Boosts Stock Position in Astera Labs, Inc. $ALAB

BNP Paribas Financial Markets increased its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 577.3% during the 3rd quarter, Holdings Channel reports. The firm owned 1,127,340 shares of the company’s stock after buying an additional 960,899 shares during the period. BNP Paribas Financial Markets’ holdings in Astera Labs were worth $220,733,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Assetmark Inc. raised its position in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the last quarter. Clearstead Trust LLC increased its stake in shares of Astera Labs by 46,100.0% during the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after buying an additional 461 shares during the period. Advisors Asset Management Inc. increased its stake in shares of Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after buying an additional 194 shares during the period. Manchester Capital Management LLC raised its holdings in shares of Astera Labs by 141.5% during the second quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after acquiring an additional 283 shares in the last quarter. Finally, Pinpoint Asset Management Singapore Pte. Ltd. bought a new position in shares of Astera Labs during the third quarter valued at approximately $47,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Down 4.8%

Shares of Astera Labs stock opened at $116.48 on Wednesday. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The firm has a market capitalization of $19.83 billion, a P/E ratio of 95.48, a P/E/G ratio of 2.41 and a beta of 1.74. The business has a fifty day simple moving average of $150.84 and a two-hundred day simple moving average of $169.21.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. During the same period in the prior year, the firm earned $0.37 EPS. The company’s revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 94,971 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the transaction, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at approximately $179,863,615.59. This trade represents a 6.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the transaction, the general counsel owned 128,084 shares of the company’s stock, valued at $15,046,027.48. The trade was a 7.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 224,292 shares of company stock valued at $27,676,069. Insiders own 12.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on ALAB shares. Northland Securities boosted their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Royal Bank Of Canada began coverage on shares of Astera Labs in a research note on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Citigroup decreased their price target on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Finally, Wall Street Zen cut Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $195.89.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.